Diagnostic Radiopharmaceuticals

Diagnostic Radiopharmaceuticals Companies (2)

Diagnostic Radiopharmaceuticals Products (5)

  • Product Iohexol Injection USP

    Iohexol Injection a radiographic contrast medium indicated for intrathecal administration in adults including myelography (lumbar, thoracic, cervical, total columnar) and in contrast enhancement for computerized tomography (myelography, cisternography, ventriculography).

  • Product Iodixanol Injection USP

    Iodixanol is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents. It is indicated for intra-arterial digital subtrac...
  • Product Gadobutrol Injection

    Gadobutrol injection is a magnetic resonance imaging (MRI) contrast agent that is used to help create a clear picture of the body during an MRI scan. MRI scans are a special kind of procedure that lets a doctor look at the inside of the body, such as the brain. They use magnets and computers to create imag...
  • Product Gadoterate Meglumine Injection

    Gadoterate Meglumine is a gadolinium chelate paramagnetic contrast agent. When placed in a magnetic field, gadoterate meglumine produces a large magnetic moment and so a large local magnetic field, which can enhance the relaxation rate of nearby protons; as a result, the signal intensity of tissue images o...
  • Product Iopamidol Injection USP

    Iopamidol Injection USP is a contrast medium used for intrathecal administration in neuroradiology including myelography (lumbar, thoracic, cervical, total columnar), and for contrast enhancement of computed tomographic (CECT) cisternography and ventriculography.

Upcoming Events

  • CPHI Middle East 2024

    Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
    10 Dec 2024 - 12 Dec 2024
  • Pharmapack Europe 2025

    Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
    22 Jan 2025 - 23 Jan 2025
  • CPHI Japan 2025

    East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
    09 Apr 2025 – 11 Apr 2025

Pharmaceutical Industry Webinars